CD19 and polycystic ovary syndrome: We also suggest caution toward therapeutically targeting CD19+ cells as DHT-exposed B cell-deficient mice develop a PCOS-like phenotype, showing that a lack of B cells is not protective and reiterates the need for broader studies on alterations of the immune system within the complex hormonal frame of PCOS, including activation of T cells and tissue-resident immune cells.